Cenduit expands in Europe and U.S.

Tuesday, February 26, 2013 10:04 AM

Cenduit, a global provider of patient randomization and clinical supplies management services, has announced the expansion of its Durham, N.C., headquarters and its office in Basel, Switzerland. The expansion adds substantial space to the company’s headquarters and triples the size of its office in Basel.

“The increase in offices and infrastructure is required to support our global investment in capacity,” said Jogin Desai, CEO. “Our aim is to provide the best possible support to sites and sponsors and to do this through continued investment in our customer-facing groups.”

News of the expansion comes in tandem with Cenduit’s recent appointment of Chris Dailey as global head of technology. Dailey joins Cenduit with more than 15 years of interactive, software and telecommunications experience. In his role as global head of technology, Dailey will lead technology and service initiatives aimed at providing additional system functionality as well as improving the user experience for those interfacing with Cenduit Interactive Response Technology (IRT) to conduct clinical trials at sites across the globe.

“The expansion and the acquisition of senior leadership like Chris give us the bandwidth to execute our plans to implement new technologies and augment the breadth of services that we provide to sponsors,” said Desai. “Our top priority is enabling investigator sites to achieve overall compliance through seamless management of patient enrollment and treatment throughout the clinical trial.” 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013

Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings

Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving

Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs